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Grafts of foetal ventral mesencephalon, used in cell replacement therapy for Parkinson’s disease, are known to contain a mix of
dopamine neuronal subtypes including the A9 neurons of the substantia nigra and the A10 neurons of the ventral tegmental
area. However, the relative importance of these subtypes for functional repair of the brain affected by Parkinson’s disease has
not been studied thoroughly. Here, we report results from a series of grafting experiments where the anatomical and functional
properties of grafts either selectively lacking in A9 neurons, or with a typical A9/A10 composition were compared. The results
show that the A9 component of intrastriatal grafts is of critical importance for recovery in tests on motor performance, in a
rodent model of Parkinson’s disease. Analysis at the histological level indicates that this is likely to be due to the unique ability
of A9 neurons to innervate and functionally activate their target structure, the dorsolateral region of the host striatum. The
ﬁndings highlight dopamine neuronal subtype composition as a potentially important parameter to monitor in order to under-
stand the variable nature of functional outcome better in transplantation studies. Furthermore, the results have interesting
implications for current efforts in this ﬁeld to generate well-characterized and standardized preparations of transplantable
dopamine neuronal progenitors from stem cells.
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Abbreviations: E=embryonic day; GFP=green ﬂuorescent protein; GIRK2=G protein activated inward rectiﬁer potassium
channel-2; Pitx3=gene encoding pituaitary homeobox 3; TH=tyrosine hydroxylase.
doi:10.1093/brain/awp328 Brain 2010: 133; 482–495 | 482
Received September 3, 2009. Revised November 20, 2009. Accepted November 24, 2009
 The Author(s) 2010. Published by Oxford University Press on behalf of Brain.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5),
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction
The nigrostriatal dopamine pathway is a key regulator of motor
function in the mammalian brain. The progressive loss of midbrain
dopamine neurons is the leading cause of motor dysfunction in
Parkinson’s disease. An effective means to restore motor function
in animal models of the disease, and potentially also in patients
with Parkinson’s disease, is to replace the missing midbrain dopa-
mine neurons through intrastriatal transplantation of foetal ventral
mesencephalic tissue (Lindvall et al., 1990; Bjo ¨rklund and Lindvall,
2000; Lindvall and Bjo ¨rklund, 2004). The midbrain dopamine
neuroblasts, dissected from the foetal brain at the time of midbrain
dopamine neurogenesis, are capable of establishing a new terminal
network within the host striatum, thus restoring afferent input to
striatal projection neurons and normalizing information ﬂow
through the damaged motor circuitry (Bjo ¨rklund et al., 1981;
Piccini et al., 2000).
The midbrain dopamine neurons are a heterogeneous popula-
tion and can be broadly divided into two principal subtypes,
including those of the substantia nigra pars compacta and ventral
tegmental area, or according to the nomenclature of Dahlstrom
and Fuxe (1964), cell groups A9 and A10, respectively. Various
criteria can be used to distinguish between these midbrain dopa-
mine neuron subtypes including morphology, protein expression,
target speciﬁcity and susceptibility to death in Parkinson’s disease
and animal models thereof. The A9 neurons are large and angular
in shape, express the potassium channel subunit G protein acti-
vated inward rectiﬁer potassium channel (GIRK)-2, project predo-
minately to the dorsolateral striatum (corresponding to putamen
and part of caudate nucleus in man), and degenerate preferentially
in Parkinson’s disease; while the A10 neurons are comparatively
small and round in shape, many express calbindin, and they inner-
vate ventral striatal and limbic areas, including nucleus accumbens
and frontal cortex, and are relatively spared in Parkinson’s disease
(McRitchie et al., 1996; Lewis and Sesack, 1997; Damier et al.,
1999; Mendez et al., 2005; Thompson et al., 2005). Although
grafts of foetal ventral mesencephalon contain a mix of both
these midbrain dopamine neuronal subtypes, the role of each of
these in functional repair of the Parkinsonian brain has not been
well addressed. In order to assess speciﬁcally the impact of A9
neurons, we have compared the structural and functional integra-
tion provided by intrastriatal grafts selectively lacking the A9 sub-
type with those of a typical mixed A9/A10 midbrain dopamine
composition. This was achieved through the use of ventral mesen-
cephalon donor tissue taken from the recently described pituitary
homeobox 3 (Pitx3)-green ﬂuorescence protein (GFP) mouse, in
which GFP has been knocked into the Pitx3 gene locus (Zhao
et al., 2004). While the midbrain dopamine neurons develop nor-
mally in mice heterozygous for GFP (Pitx3
WT/GFP), mice in which
GFP has been knocked into both alleles (Pitx3
GFP/GFP) are Pitx3
knockouts and display a phenotype in which there is selective loss
of A9 neurons but sparing of A10 neurons in the midbrain
(Maxwell et al., 2005). Results from analysis of animals grafted
with either Pitx3
WT/GFP or Pitx3
GFP/GFP derived ventral mesence-
phalon tissue show that the A9 component of foetal ventral
mesencephalon grafts is of critical importance for re-establishment
of a new dopaminergic terminal network in the dorsolateral region
of the host striatum, and restoration of motor function in an
animal model of Parkinson’s disease.
Materials and methods
Animals
Adult female Sprague Dawley rats (225–250g) were used as graft
recipients in these experiments and were housed on a 12h light/
dark cycle with ad libitum access to food and water. Adult Pitx3-
GFP mice (Zhao et al., 2004), on a C5Bl6/129 background, were
housed under the same conditions and used to generate embryos as
a source of donor tissue for transplantation. All procedures were
conducted in accordance with guidelines set by the Ethical
Committee for the use of laboratory animals at Lund University.
Ventral mesencephalon cell
suspensions
Timed pregnant mice [day of vaginal plug was designated embryonic
day 0.5 (E0.5)] were generated by crossing male Pitx3-GFP mice
homozygous for GFP (Pitx3
GFP/GFP) with heterozygous (Pitx3
WT/GFP)
females to yield an approximately equal mix of Pitx3
GFP/GFP and
Pitx3
WT/GFP embryos. At E12.5, embryos were removed from the
pregnant females after lethal exposure to CO2, and Pitx3
GFP/GFP and
Pitx3
WT/GFP embryos were identiﬁed and separated under a ﬂuores-
cent dissection microscope on the basis of the prominent deﬁcit in lens
development in the Pitx3
GFP/GFP mice (Fig. 1A–B). The ventral mesen-
cephalon was dissected from each embryo in L-15 medium
(Invitrogen) as previously described (Dunnett and Bjo ¨rklund, 1992,
2002) and Pitx3
GFP/GFP and Pitx3
WT/GFP ventral mesencephalon
tissue pieces were pooled in separate groups (around 20 per group).
Each preparation was incubated in Hank’s buffered salt
solution
 Ca2+/Mg2+ (Invitrogen) containing trypsin (0.1%; Sigma) and
DNase (0.05%; Sigma) for 20min at 37 C and then mechanically
dissociated into a single cell suspension as described by Nikkhah
et al. (1994). Viable cell numbers were estimated on the basis of
trypan blue (Sigma) exclusion and after centrifugation (500g, 5min,
4 C), the supernatant was removed and the cells were re-suspended in
Hank’s buffered salt solution
 Ca2+/Mg2+ (Invitrogen) at a concentration
of 0.8 10
5 (Pitx3
WT/GFP) or 1.5 10
5 (Pitx3
GFP/GFP) viable cells/ml.
The cell preparations were stored on ice during the transplantation
procedure.
6-Hydroxydopamine lesions and
transplantation
All surgical procedures were conducted under general anaesthesia
using a 20:1 fentanyl and medetomidine solution injected intraperito-
neally (i.p.) (Apoteksbolaget, Sweden). The nigrostriatal dopamine
pathway was partially lesioned in the host rats through intrastriatal
injection of 2ml 6-hydroxydopamine (3.5mg/ml free base dissolved in
a solution of 0.2mg/ml L-ascorbic acid in 0.9% W/V NaCl) at each of
four sites as described by Kirik et al. (1998), using a stereotaxic appa-
ratus (Stoelting) and a 10ml Hamilton syringe ﬁtted with a glass cap-
illary. Three weeks later, the effect of the lesion on motor function was
assessed according to rotational behaviour following administration of
D-amphetamine (2.5mg/kg; i.p.), and forelimb asymmetry in the
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(n=8 per group) according to values for both behavioural measures.
Limiting values for inclusion were 56 turns/min (over 90min) for
rotational asymmetry and 425% use of the forelimb contralateral to
the lesion in the cylinder test. Three weeks after the behavioural
pre-testing (6 weeks after lesioning) animals received intrastriatal
grafts of single cell ventral mesencephalon suspension derived
from either Pitx3
WT/GFP (n=8) or Pitx3
GFP/GFP (n=8) donor mice
based on a micro-transplantation approach using a glass capillary
attached to a 5ml Hamilton syringe, as described by Nikkhah
et al. (2000). A total of 1ml of cell suspension was injected into
the head of the striatum over 2min at 0.5mm anterior and 3.0mm
lateral to bregma, 5.0mm below the dural surface, and the capil-
lary was left in place a further 2min before withdrawal. The survival
time for these animals was 12 weeks, at which point the brains
were processed for immunohistochemistry. Immunosuppressive
treatment in the form of daily i.p. injections of cyclosporine A
(15mg/kg, Weeks 1–3; 10mg/kg, Weeks 4–12; Novartis) was admin-
istered throughout the experiment, beginning the day prior to
transplantation.
Behavioural analysis
Three weeks prior to grafting and at 8 and 12 weeks following trans-
plantation, the two grafted groups, as well as non-grafted, lesioned
(n=8) and intact (n=6) control groups were assessed for motor func-
tion based on amphetamine-induced rotational behaviour and cylinder
testing.
Analysis of amphetamine-induced rotation was performed in auto-
mated rotational bowls (AccuScan Instruments) as described previously
(Ungerstedt and Arbuthnott, 1970). D-Amphetamine sulphate was
delivered (i.p.) at 2.5mg/kg and full body rotations were recorded
over a period of 90min. The data are expressed as net full body
turns per min where rotation toward the side of the lesion was
given a positive value.
The cylinder test was performed as previously described (Schallert
et al., 2000; Kirik et al., 2001) as a measure of spontaneous forelimb
use. Animals were individually placed in a glass cylinder (diameter,
20cm) and weight-bearing forepaw contacts with the glass resulting
from spontaneous exploratory behaviour were recorded. A total of
20 contacts were recorded per animal and the data are presented as
Figure 1 GFP expression in the Pitx3-GFP mouse. Low-magniﬁcation images show GFP expression (native emission signal) in the
Pitx3
WT/GFP (A) and Pitx3
GFP/GFP (B) embryo (E12.5). The eyes are enlarged as insets and illustrate the malformed lens in the Pitx3
GFP/GFP
embryo. (C) In the embryonic (E12.5) brain GFP expression was seen exclusively in the ventral mesencephalon. Dashed lines indicate the
area dissected for preparation of the cell suspensions used for grafting. Immunohistochemistry for GFP (green; D, F) and TH (red; D, E)
shows that GFP is expressed in dopamine neurons throughout the adult midbrain. The boxed areas illustrate the morphology of GFP
+/TH
+
neurons (G), with large soma and neuritic processes, and also the small number of GFP
+/TH
  cells around the midline (H), which were
small in size and lack any obvious processes. Scale: D–F, 200mm.
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metric paw use in an unbiased animal would be 50% (10/20 contacts).
Tissue processing and
immunohistochemistry
Animals received a terminal dose of 60mg/kg sodium pentobarbitone
i.p. (Apoteksbolaget, Sweden) and were trans-cardially perfused with
50ml saline (0.9% w/v), followed by 200ml ice-cold paraformalde-
hyde (4% w/v in 0.1M phosphate buffered saline). The brains
were removed, post-ﬁxed for 2h in 4% paraformaldehyde and
cryo-protected overnight in sucrose (25% w/v in 0.1M phosphate
buffered saline) before being sectioned on a freezing microtome
(Leica). Coronal sections were collected in 12 series at a thickness of
35mm.
Immunohistochemical procedures were performed as has previously
been described in detail (Thompson et al., 2005). Free-ﬂoating sec-
tions were incubated with primary antibodies overnight at room tem-
perature in an incubation solution of 0.1M phosphate buffered saline
with potassium containing 5% normal serum and 0.25% Triton X-100
(Amresco, USA). Secondary antibodies were diluted in phosphate buf-
fered saline with potassium containing 2% normal serum and 0.25%
Triton X-100 and applied to the original solution for 2h at room tem-
perature. Detection of the primary–secondary antibody complexes was
achieved by peroxidase driven precipitation of di-amino-benzidine, or
conjugation of a ﬂuorophore (either directly to the secondary antibody
or with a streptavidin–biotin ampliﬁcation step where necessary). For
detection of c-Fos, nickel sulphate (2.5mg/ml) was used to intensify
the staining. Slide mounted sections labelled with ﬂuorescent markers
were cover-slipped with polyvinyl alcohol-1,4-diazabicyclo[2.2.2]-
octane (Peterson, 1999) and di-amino-benzidine labelled sections
were dehydrated in alcohol and xylene and cover-slipped with
DePeX mounting media (BDH Chemicals, UK). Primary antibodies
and dilution factors were as follows: mouse anti-Calbindin28KD
(1:1000: Sigma), rabbit anti-c-Fos (1:5000, Calbiochem), chicken
anti-GFP (1:1000; Abcam), rabbit anti-GFP (1:20000; Abcam), rabbit
anti-GIRK2 (1:100; Alomone Labs, Jerusalem, Israel) rabbit anti-PITX3
(1:100; Invitrogen) and mouse anti-tyrosine hydroxylase (TH: 1:4000;
Chemicon). Secondary antibodies, used at a dilution of 1:200, were as
follows: (i) direct detection—cyanine 3 or cyanine 5 conjugated
donkey anti-mouse, cyanine 2 conjugated donkey anti-chicken, cya-
nine 5 conjugated donkey anti-mouse (Jackson ImmunoResearch); and
(ii) indirect with streptavidin-biotin ampliﬁcation—biotin conjugated
goat anti-rabbit or horse anti-mouse (Vector Laboratories) followed
by peroxidase conjugated streptavidin (Vectastain ABC kit, Vector
laboratories), or cyanine 2/cyanine 5 conjugated streptavidin
(Jackson ImmunoResearch).
Imaging
All ﬂuorescent images were captured using a Leica DMRE confocal
microscope equipped with green helium/neon, standard helium/neon
and argon lasers. The macroscopic, ﬂuorescence image of an embry-
onic Pitx3-GFP brain illustrated in Fig. 1 was acquired using a dissec-
tion microscope (Leica) equipped with a digital camera (Progres).
Densitometry
The area of re-innervated striatum around the grafts was calculated in
the dorsolateral or ventromedial quadrant from two tyrosine hydroxy-
lase-stained sections (+0.20 and  0.30mm from bregma), as depicted
in Fig. 6, using Image J software (Version 1.32j, National Institutes of
Health, USA). The entire striatum was divided into quarters, and in
sections where cell bodies were visible, the core of the graft was
excluded from the analysis. The measured values were corrected for
non-speciﬁc background staining by subtracting values obtained from
the corpus callosum. The data are expressed as optical density as a
percentage of the corresponding area from the intact side, and values
from both sections were combined to provide a single value for each
region.
Estimation of c-Fos
+ cell numbers
To evaluate changes in c-Fos expression in the striatal neurons, animals
were sacriﬁced 2h after an i.p. injection of 2.5mg/kg D-amphetamine.
High-resolution images were captured from two sections, at +0.20
and  0.30mm from bregma, using a Scanscope GL system with
Imagescope v8.2 software. A 0.8 0.8 mm
2 area medial and lateral to
the graft was selected for analysis using the Image J software. The
intense staining of c-Fos
+ nuclei and low background allowed for
software-automated calculation of the total number of c-Fos
+ cells
based on optical density upon deﬁning the threshold for speciﬁc signal.
Cell counting
The small size of the grafts allowed for identiﬁcation and counting of
all GFP
+ dopamine neurons in each tissue series, thus avoiding the
need for stereological counting procedures The total number of
GFP
+ cells in the intrastriatal grafts was estimated for each animal
through extrapolation of the number of GFP positive cells counted
in every sixth coronal section. The method of Abercrombie (1946)
was used to correct for double counting caused by cells spanning
more than one section. Relative numbers of Calbindin
+/GFP
+,
GIRK2
+/GFP
+ or Calbindin
+/GIRK2
+/GFP
+ cells were estimated by
confocal analysis of every sixth coronal section from each animal fol-
lowing triple-immunohistochemical labelling for these proteins. The
data are represented as the contribution of each of these three cell
types to the graft as a percentage of the total number of GFP
+ cells
expressing either GIRK2 and/or Calbindin.
Statistics
All data are expressed as mean the standard error of the mean. All
statistical analyses were conducted using the Statistical Package for the
Social Sciences 17 (SPSS Inc.). A two-tailed Student’s t-test was used
to compare the average number of GFP
+ cells in the two groups of
grafted animals. The average density of tyrosine hydroxylase positive
(TH
+) ﬁbres and the number of c-Fos
+ cells in each group were com-
pared using a one-way ANOVA with a Tukey post hoc. Two-way
ANOVA was performed on all behavioural data using the generalized
linear model and the Wald 
2 followed by individual
Bonferroni-corrected one-way ANOVA for each time point with
Tukey post hoc analysis.
Results
GFP expression in the developing and
adult Pitx3-GFP knock-in mouse
In the developing embryo, GFP expression was observed through-
out the skeletal musculature, in the ventral mesencephalon and
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At E12.5, the Pitx3
GFP/GFP and Pitx3
WT/GFP genotypes could
clearly be distinguished based on the greater intensity of GFP
and also malformation of the lens in Pitx3
GFP/GFP embryos
(Fig. 1A and B). These features allowed for separation of the
two genotypes and pooling of the ventral mesencephalons dis-
sected from each foetus prior to preparation of the cell suspen-
sions. In the adult brain, immunohistochemical analysis showed
that GFP expression was almost exclusively conﬁned to TH expres-
sing dopamine neurons residing in the substantia nigra and ventral
tegmental area regions of the midbrain (Fig. 1C and D). One
exception was around the midline, where there were a number
of GFP
+/TH
  cells residing in the interfasicular and anterior linear
raphe nuclei (Fig. 1D). When compared with the TH expressing
neurons, this was a relatively minor population in number, com-
prising cells with a small soma and few discernable processes.
Within the substantia nigra and ventral tegmental area, there
was almost complete overlap between TH and GFP expression,
with only some few scattered TH
+/GFP
  neurons and no apparent
TH
 /GFP
+ cells.
In order to generate mice with GFP knocked into either one
(Pitx3
WT/GFP) or both (Pitx3
GFP/GFP) Pitx3 alleles, Pitx3
GFP/GFP
males were bred with Pitx3
WT/GFP females. This yielded mixed
litters at the expected Mendelian frequency of approximately
50% for each genotype. In agreement with the original report
by Maxwell and colleagues (2005), immunohistological analysis
of the adult midbrain conﬁrmed that PITX3 expression was present
in Pitx3
WT/GFP mice but completely abolished in Pitx3
GFP/GFP lit-
termates (Fig. 2E and F). While heterozygous Pitx3
WT/GFP mice
appeared indistinguishable from wild-type animals at the beha-
vioural and histological level (not shown), the Pitx3
GFP/GFP knock-
outs displayed a phenotype which is very similar, if not identical,
to the previously described aphakia mice (Nunes et al., 2003;
Smidt et al., 2004). The knockout animals were smaller in size
than Pitx3
WT/GFP littermates, had a small eye phenotype and
histological analysis revealed a prominent loss of dopamine neu-
rons within the substantia nigra pars compacta (Fig. 2A and C).
This pattern of cell loss was reﬂected at the level of the striatum,
where there was an almost complete loss of innervation of areas
normally innervated by the A9 midbrain dopamine neurons, most
notably the dorsolateral striatum, while areas innervated by A10
midbrain dopamine neurons, such as nucleus accumbens and adja-
cent areas of the ventromedial striatum, appeared relatively
intact (Fig. 2B and D). The selective loss of A9 neurons in the
Pitx3
GFP/GFP knockouts was also apparent based on expression of
GIRK2 and Calbindin, which are largely conﬁned to the A9 and
A10 populations, respectively (Fig. 3). While there was an almost
complete loss of the GFP
+/GIRK2
+ midbrain dopamine population
throughout the substantia nigra pars compacta in the Pitx3
GFP/GFP
mice (Fig. 3C and D), the GFP
+/Calbindin
+ midbrain dopamine
neurons in the ventral tegmental area were largely spared (Fig. 3E
and F). The GIRK2
+ neurons present in the dorsolateral part of the
ventral tegmental area were also spared (Fig. 3D).
Functional impact of Pitx3
WT/GFP and
Pitx3
GFP/GFP ventral mesencephalon
grafts
We made use of ventral mesencephalon dissected from either the
Pitx3
WT/GFP or Pitx3
GFP/GFP genetic backgrounds to prepare two
different cell preparations for transplantation. Given that the mid-
brain in Pitx3
GFP/GFP mice contains approximately half the number
of midbrain dopamine neurons seen in Pitx3
WT/GFP mice (Maxwell
et al., 2005), cell suspensions were prepared such that
Pitx3
GFP/GFP preparations contained twice the cell concentration
(1.5 10
5 cells/ml) relative to Pitx3
WT/GFP preparations (0.8 10
5
cells/ml), in order to achieve grafts with a similar total number
of midbrain dopamine neurons. One microlitre of cell suspen-
sion was injected into the head of striatum in intrastriatal
Figure 2 The Pitx3 knockout phenotype. Immunohistochemistry for TH in the adult Pitx3
WT/GFP (A, B) and Pitx3
GFP/GFP (C, D) brain.
In Pitx3
GFP/GFP mice there was a distinct loss of TH
+ neurons throughout the substantia nigra (compare A and C) and a corresponding loss
of TH
+ terminals in the dorsolateral striatum (compare B and D). Immunohistochemistry for TH (red), GFP (green) and PITX3 (blue) shows
PITX3 expression in midbrain dopamine neurons in Pitx3
WT/GFP mice (E) and lack of expression in the Pitx3
GFP/GFP (Pitx3 null) mice (F).
CPu=caudate-putamen unit; NAc=nucleus accumbens; SN=substantia nigra; VTA=ventral tegmental area. Scale: A and C, 200mm; B
and D, 500mm; E–F,5 0mm.
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deﬁcits, as determined by amphetamine-induced rotational behav-
iour and impaired forelimb use in the cylinder test. By 8 weeks
post-grafting the Pitx3
WT/GFP grafted animals showed signiﬁcant
reduction in rotational behaviour, while the Pitx3
GFP/GFP grafted
group and the lesion-only controls remained impaired. This
effect was maintained at 12 weeks post-transplantation (Fig. 4A;
group time, 2
ð6,75Þ =27.89, P50.0001; post-transplantation dif-
ference conﬁrmed using a Bonferroni-adjusted one-way ANOVA
with a Tukey post hoc test, P50.05). The Pitx3
WT/GFP group also
showed a signiﬁcant improvement in performance in the cylinder
test at 12 weeks compared to both lesion controls and the
Pitx3
GFP/GFP group, which did not show any sign of improvement
at either time-point (Fig. 4B; group time, 
2
(6,75)=38.82,
P50.0001; the difference at week 12 was conﬁrmed using a
Bonferroni-adjusted one-way ANOVA with a Tukey post hoc
test, P50.05).
Connectivity of Pitx3
WT/GFP and
Pitx3
GFP/GFP ventral mesencephalon
grafts
Twelve weeks after transplantation, immunohistochemistry for
GFP showed 8/8 and 7/8 surviving grafts in animals transplanted
with Pitx3
WT/GFP or Pitx3
GFP/GFP cells, respectively. The vast
majority of GFP expressing cells in the grafts were also
TH-positive (Fig. 5A–C). As in the intact Pitx3-GFP midbrain, we
Figure 3 Subtype-speciﬁc pattern of dopamine neuronal cell loss in Pitx3 knockouts. Immunohistochemistry for GFP (green; A, B, G, H),
GIRK2 (red; C, D, G, H) and Calbindin (blue; E, F, G, H) in the adult Pitx3
WT/GFP (A, C, E, G) and Pitx3
GFP/GFP (B, D, F, H) brain. In the
Pitx3
GFP/GFP midbrain there was a substantial loss of the GIRK2
+/GFP
+ midbrain dopamine neurons throughout the substantia nigra pars
compacta (arrows in C and D indicate the substantia nigra pars compacta). A population of GIRK2
+ midbrain dopamine neurons residing in
the dorsolateral part of the ventral tegmental area (arrowhead in C, D) appeared to be less affected in the Pitx3 knockout animals.
The Calbindin
+/GFP
+ midbrain dopamine population was also left relatively intact in the Pitx3
GFP/GFP midbrain (E, F). Scale: 200mm.
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+ cells
that were not immunoreactive for TH (Fig. 5C). These cells had
few, if any, dendritic processes and were predominately located in
the central part of the graft. Counting of GFP
+ cells revealed that
the total number of surviving midbrain dopamine neurons was
not different between Pitx3
WT/GFP (2517 215; 3.1 0.3% of
cells injected) and Pitx3
GFP/GFP (2079 405; 1.4 0.3%) grafts
(P=0.95).
The Pitx3 driven GFP expression could be detected not only at
the level of the cell bodies but also throughout the dendritic and
axonal processes of the grafted dopamine neurons. This allowed
us to assess and compare the degree of graft-derived dopaminer-
gic ﬁbre outgrowth from Pitx3
WT/GFP and Pitx3
GFP/GFP grafts using
GFP. Immunohistochemistry for GFP revealed a clear difference in
the ability of the different graft types to innervate the host stria-
tum. This was particularly evident in the dorsolateral region, where
the Pitx3
WT/GFP grafts provided extensive innervation, as a homog-
enous terminal network, while innervation from Pitx3
GFP/GFP grafts
was sparser and had a patchy appearance (Fig. 6D–E). To evaluate
the ability of the different graft types to innervate the host stria-
tum relative to that normally provided by the intact system, the
density of the TH
+ terminal network was assessed in grafted ani-
mals from both groups and compared to TH
+ ﬁbre density in the
intact and lesioned striatum. Figure 6 shows TH immunohisto-
chemistry in coronal sections from representative animals
from the 6-hydroxydopamine lesion control group (A) and the
Pitx3
WT/GFP (B) and Pitx3
GFP/GFP (C) grafted groups. The pattern of
TH staining in the lesion control animal (Fig. 6A) illustrates the par-
tial denervation induced by the intrastriatal 6-hydroxydopamine
lesion. At the level of the midbrain, there was a near complete
Figure 4 Functional impact of the intrastriatal grafts. Rotational behaviour in response to D-amphetamine (5mg/kg, i.p.) prior to grafting
and at 8 and 12 weeks after transplantation is shown as net rotations/minute (over 90min) for the two grafted groups (Pitx3
WT/GFP, open
boxes, n=8;Pitx3
GFP/GFP, grey boxes, n=7), as well as ungrafted intact (ﬁlled circles, n=6) and 6-hydroxydopamine lesioned (open
circles, n=8) control groups (A). In the three lesioned groups, there was a prominent rotational bias (415 turns/minute) in the direction
ipsilateral to the 6-hydroxydopamine lesion at one week prior to transplantation. At the post-transplantation time-points only in the
Pitx3
WT/GFP group was the average rotational score normalized to levels signiﬁcantly below the lesion control group ( P50.05). Forelimb
preference in the cylinder test was assessed prior to grafting and at the same 8 and 12 week post-transplantation time-points (B; group
numbers and symbols are the same as quoted for A). The intact group did not display any obvious bias for spontaneous forelimb use
throughout the test procedure (on average around 50% use of the forelimb contralateral to the lesion). The three 6-hydroxydopamine
lesioned groups all displayed prominent impairment in use of the contralateral forelimb (525% use) prior to grafting. Only in the Pitx3
WT/
GFP group was there a signiﬁcant improvement in contralateral forelimb use over the ungrafted lesion control group, and only at the
12 week time-point ( P50.05). See main text for details of statistical analyses.
Figure 5 Expression of the GFP reporter in intrastriatal ventral
mesencephalon grafts. Immunohistochemistry for GFP (green;
A–C) and TH (red; A–C) in a coronal section through the stria-
tum from a representative animal 12 weeks after transplantation
of ventral mesencephalon cells from the Pitx3
WT/GFP donor
group. The boxed areas are shown in greater detail on the left as
individual and merged colour channels and illustrate the overlap
between TH and GFP that is the case for the vast majority of
GFP
+ cells (B) and also the population of small TH
 /GFP
+ cells
that tended to cluster in more central parts of the grafts (C).
Scale: 200mm.
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WT/GFP and Pitx3
GFP/GFP grafts. Immunohistochemistry for TH in representative coronal sections from the
ungrafted lesion control (A), Pitx3
WT/GFP graft (B), and Pitx3
GFP/GFP graft (C) groups, 12 weeks after transplantation. Two sections
through the forebrain ( bregma+3.0mm, left section and  2.0mm, middle section) and one section through the midbrain are shown.
The left-hand side of the lesion control brain shows the intact nigrostriatal projection system, while the right-hand side illustrates the
substantial loss of TH
+ neurons from the substantia nigra and reduction of TH
+ terminal staining in the dorsolateral striatum resulting from
the terminal 6-hydroxydopamine lesion (A). Dashed lines in (A) identify the dorsolateral (a) and ventromedial (b) quadrants of the striatum
used to quantify TH
+ ﬁbre density in the three groups. Boxed areas are enlarged and illustrate the level of TH
+ terminal staining in the
Continued
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+ midbrain dopamine neurons in the substantia nigra
pars compacta, while TH
+ neurons in the ventral tegmental area
were partially spared. This was reﬂected in the striatum, where
TH
+ terminal density was markedly reduced to 18 3% of
intact levels in the dorsolateral region (area a, Fig. 6A and F),
whereas the ventromedial region was less severely dennervated
(to 48.1 6.5% of intact levels; area b, Fig. 6A and F).
Consistent with the results obtained with GFP staining, the two
different graft types displayed a marked difference in their ability
to reinnervate the striatum and this was most evident in the dor-
solateral region. Densitometry of TH-stained sections showed that
TH
+ innervation in the dorsolateral striatum was signiﬁcantly
greater in animals grafted with Pitx3
WT/GFP ventral mesencephalon
(31.4 2.2% of intact) when compared with animals grafted with
Pitx3
GFP/GFP ventral mesencephalon (18.4 3.5%) or ungrafted
lesioned controls (area a, Fig. 6A, B, C and F; 18.9 2.4%;
F(2,22)=7.73, P50.005; conﬁrmed using a Tukey post hoc test).
In the ventromedial striatum, by contrast, the TH
+ terminal density
was not signiﬁcantly increased over the average ungrafted lesion
control value (48.1 6.5%) in either the Pitx3
WT/GFP
(51.6 2.7%) or the Pitx3
GFP/GFP (54.3 8.8%) groups [area b,
Fig. 6A, B, C and F; F(2,20)=0.24, P=0.79].
A similar region-speciﬁc difference in the striatum between the
two groups of grafted animals was observed in the
amphetamine-induced expression of the early immediate response
gene, c-Fos (Fig. 7A–C). In the two grafted groups and also in the
ungrafted, lesion control animals, the number of c-Fos
+ nuclei
were counted in a 0.8 0.8mm area medial and lateral to the
graft. In a lateral part of the striatum, the average number of
c-Fos
+ cells was similar in the Pitx3
GFP/GFP (199.8 19.9) and
the lesion-only control groups (193.0 23.4), but signiﬁcantly
greater in the Pitx3
WT/GFP grafted animals (318.4 38.6) [Fig.
7D; F(3,24)=4.57, P50.05, conﬁrmed using a Tukey post hoc
test]. In a medial part of the striatum, the average number of
c-Fos
+ cells was not signiﬁcantly different between all three
groups [lesion control, 429.0 61.1; Pitx3
WT/GFP, 355.3 32.1;
Pitx3
GFP/GFP, 352.5 36.7; F(3,24)=0.71, P=0.558].
Dopamine neuronal subtype
composition of Pitx3
WT/GFP and
Pitx3
GFP/GFP ventral mesencephalon
grafts
Although the two groups of grafted animals contained similar
total numbers of GFP
+ midbrain dopamine neurons,
immunohistochemistry for GIRK2 and Calbindin revealed substan-
tial differences in midbrain dopamine subtype composition
between the two graft types. The Pitx3
WT/GFP grafts contained a
mix of GIRK2 and Calbindin-expressing GFP
+ cells such that the
largest population, 65 2%, was GIRK2
+, while 26 2% were
Calbindin
+ and 9 0.3% expressed both proteins (Fig. 8A and
C). The Pitx3
GFP/GFP grafts, by contrast, were dominated by the
calbindin
+ cell type (68 3%), with only 15 2% GIRK2
+, and a
remaining 17 2% expressing both markers (Fig. 8B and C). Both
graft types also contained a small population of GFP
+ cells that
expressed neither GIRK2 nor Calbindin and, based on size and
location, most of these appeared to correspond to the small, mid-
line population of GFP
+/TH
  cells (data not shown).
Discussion
Previous studies have shown that grafts of foetal ventral mesen-
cephalon tissue contain a mix of midbrain dopamine neuronal cell
types including those of both the substantia nigra pars compacta
(A9) and ventral tegmental area (A10) subtypes (Mendez et al.,
2005; Thompson et al., 2005). We report here that the A9 mid-
brain dopamine sub-population is of critical importance for struc-
tural and functional dopamine neuron replacement in the
Parkinsonian brain. To address the role of the A9 component in
intrastriatal ventral mesencephalon grafts speciﬁcally, we made
use of donor tissue from Pitx3-GFP reporter mice. The knock-in
design of these mice makes possible complete deletion of
the Pitx3 gene by substitution at both alleles with GFP
(Pitx3
GFP/GFP). Alternatively, the mice can be bred as heterozy-
gotes, carrying copies of both the Pitx3 and GFP genes
(Pitx3
WT/GFP). The expression pattern of GFP in animals of either
genotype was consistent with the known expression of PITX3 in
the midbrain (Smidt et al., 1997), lens (Semina et al., 1997) and
skeletal muscle (Coulon et al., 2007). On closer examination of
the fully developed midbrain, we found the GFP expression to
match faithfully with TH expressing dopamine neurons throughout
the ventral tegmental area and substantia nigra pars compacta
domains of animals from both genotypes, and thus to be an excel-
lent surrogate marker of midbrain dopamine neuronal identity.
In agreement with the original description of the Pitx3
GFP/GFP
phenotype (Maxwell et al., 2005), we observed a selective loss
of substantia nigra neurons in these mice and relative sparing of
ventral tegmental area neurons. This pattern of cell loss resulting
from Pitx3 deletion is consistent with the midbrain phenotype
Figure 6 Continued
dorsolateral striatum from each group. Part of the grafts, containing intensely TH
+ cell bodies, can be seen on the left side of the boxed
panels from the two grafted groups (B, C). Darkﬁeld photographs illustrate immunohistochemical detection of GFP in the dorsolateral
striatum in Pitx3
WT/GFP graft (D) and Pitx3
GFP/GFP graft (E) groups. The graft core (G) can be seen in the lower left part of these panels.
The average levels of TH
+ ﬁbre density in the dorsolateral (area a) and ventromedial (area b) parts of the striatum are shown for the
ungrafted lesion control (open bars, n=8), Pitx3
WT/GFP (grey bars, n=8) and Pitx3
GFP/GFP (black bars, n=7) graft groups (F). The ﬁgures
are given as a percentage of the TH
+ density values obtained in corresponding regions from the intact striatum. In the dorsolateral striatum
(area a), the TH
+ ﬁbre density was signiﬁcantly greater in the Pitx3
WT/GFP grafted group compared to the lesion control or Pitx3
GFP/GFP
graft groups ( P50.005). There was no signiﬁcant difference in the level of TH
+ ﬁbre density in the ventromedial striatum (area b)
between the three groups. CPu=caudate-putamen unit; NAc = nucleus accumbens; cc=corpus callosum; G=graft; SN=substantia nigra;
VTA=ventral tegmental area. See main text for details of statistical analyses. Scale: A–C, 2mm; D and E, 200mm.
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the Pitx3 gene (Nunes et al., 2003; Smidt et al., 2004). The selec-
tive nature of the midbrain dopamine neuronal loss was also evi-
dent based on the distribution of GIRK2
+ and Calbindin
+ cell types
in the substantia nigra pars compacta and ventral tegmental area.
In the intact midbrain, the expression of the GIRK2 and Calbindin
proteins can broadly be used to identify the A9 and A10 midbrain
dopamine populations, respectively (Mendez et al., 2005;
Thompson et al., 2005). The majority of the A9 neurons are
located within the substantia nigra pars compacta and have a
GIRK2
+/Calbindin
  phenotype, while the A10 neurons lie in the
ventral tegmental area and the adjacent so-called dorsal tier of the
substantia nigra, and predominately have a GIRK2
 /Calbindin
+
identity. Cells expressing both markers are found in the dorsolat-
eral ventral tegmental area, in the transition zone between ventral
tegmental area and substantia nigra. The most prominent change
in the Pitx3
GFP/GFP midbrain was a loss of GIRK2
+/Calbindin
  neu-
rons in the substantia nigra pars compacta.
Analysis of GIRK2 and Calbindin expression in the transplants of
grafted animals showed that the different midbrain phenotypes
of the two genetic backgrounds were closely reﬂected in the
midbrain dopamine composition of grafts derived from either
Pitx3
WT/GFP or Pitx3
GFP/GFP donors. The Pitx3
WT/GFP grafts con-
tained a substantial proportion of GIRK2
+ midbrain dopamine neu-
rons—around 74% of all GIRK2/Calbindin expressing GFP
+
neurons, including 65 2% GIRK2
+/Calbindin
  and 9 0.3%
that expressed both proteins. The Pitx3
GFP/GFP grafts, on the
other hand, contained around 32% GIRK2
+ neurons, of which
only 15 2% were GIRK2
+/Calbindin
  and 17 2% expressed
both GIRK2 and Calbindin. The midbrain dopamine neurons
expressing both GIRK2 and Calbindin, which were found in similar
numbers in both graft types, are very likely to represent the
GIRK2
+ population found in the dorsolateral part of the ventral
tegmental area, which is less affected in the Pitx3
GFP/GFP midbrain.
Thus, the most striking difference between the two graft types
was the loss of GIRK2
+/Calbindin
  cell types in the Pitx3
GFP/GFP
Figure 7 Activation of the post-synaptic target by Pitx3
WT/GFP and Pitx3
GFP/GFP grafts. Immunohistochemistry for c-Fos in the dorso-
lateral striatum in representative coronal sections from the ungrafted lesion control (A), Pitx3
WT/GFP graft (B) and Pitx3
GFP/GFP graft (C)
groups, 12 weeks after transplantation. Dashed lines indicate the area occupied by the graft (G) in the transplanted animals. The average
number of c-Fos
+ cells in a 0.8 0.8mm area sampled from a lateral (between the graft and corpus callosum) or medial (between the graft
and lateral ventricle) part of the striatum are shown for the ungrafted lesion control (open bars, n=8), Pitx3
WT/GFP (grey bars, n=8)
and Pitx3
GFP/GFP (black bars, n=7) graft groups (D). In the lateral striatum the number of c-Fos
+ cells was signiﬁcantly greater in the
Pitx3
WT/GFP grafted group compared to the ungrafted control or Pitx3
GFP/GFP graft groups ( P50.05). There was no signiﬁcant difference
in the number of c-Fos
+ cells in the medial part of the striatum between the three groups. G=graft. See main text for details of statistical
analyses. Scale: 200mm.
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+ midbrain dopamine neu-
ronal subtypes in these grafts (up to 85%, when including both
Calbindin
+/GIRK2
  and Calbindin
+/GIRK2
+ cell types), suggesting
a substantially greater proportion of A10 midbrain dopamine sub-
types at the expense of A9 neurons.
The Pitx3
GFP/GFP grafted animals performed signiﬁcantly worse
in tests of motor function following grafting, relative to the
Pitx3
WT/GFP grafted animals. Correction of rotational asymmetry
following amphetamine challenge is the most sensitive test used to
assess graft function in unilateral models of Parkinson’s disease.
Previous studies have shown that as little as a few hundred surviv-
ing midbrain dopamine neurons are sufﬁcient to provide a
signiﬁcant reduction in amphetamine-induced turning (Sauer and
Brundin, 1991; Nakao et al., 1994; Haque et al., 1997). Although
the number of surviving midbrain dopamine neurons seen here
were well in excess of this number for both Pitx3
WT/GFP
(2517 215) and Pitx3
GFP/GFP (2079 405) grafted animals,
only the Pitx3
WT/GFP grafted animals showed improvement in
rotation scores following amphetamine challenge. This difference
is readily explained by the difference in numbers of A9 neurons
present in the two graft types: an average of 1638 GIRK2
+/
Calbindin
  cells (65% of 2517) in the Pitx3
WT/GFP grafts versus
312 GIRK2
+/Calbindin
  cells (15% of 2079) in the Pitx3
GFP/GFP
grafts. Spontaneous motor function is more resistant to
graft-induced recovery, requires more extensive graft-induced
reinnervation of the host striatum, and typically takes longer to
manifest relative to pharmacologically induced correction of motor
asymmetry (Nikkhah et al., 1993; Winkler et al., 1999). In the
cylinder test, only animals in the Pitx3
WT/GFP graft group
showed signiﬁcant improvement in contralateral forelimb use,
and only at the last time point. This longer time required for cor-
rection of spontaneous motor function may reﬂect continued
growth and maturation of the graft between 8 and 12 weeks in
order, for example, to establish a threshold level of terminal inner-
vation in the host striatum.
The ability of the two graft types to provide dopaminergic
innervation to the striatum was clearly different. Analysis of
GFP
+ or TH
+ ﬁbre patterns in the grafted animals showed that
the Pitx3
GFP/GFP grafts had a signiﬁcantly reduced capacity to
establish a terminal network within the dorsolateral striatum rela-
tive to grafts derived from the Pitx3
WT/GFP donors. Importantly,
both groups of grafted animals contained similar numbers of mid-
brain dopamine neurons placed at the same intrastriatal location.
Thus, the reduced striatal innervation seen in the Pitx3
GFP/GFP
grafts is likely to have resulted from a lower proportion of mid-
brain dopamine neurons of the A9 phenotype present in these
grafts. Notably, the difference in innervation pattern between
the two graft types, including reduced innervation of dorsolateral
aspects of striatum by Pitx3
GFP/GFP grafts, matched well with the
different patterns of striatal innervation provided by the endogen-
ous midbrain dopamine population in Pitx3
WT/GFP and Pitx3
GFP/
GFP mouse brains. The normal topography of the intrinsic nigros-
triatal projection to the striatum is such that the innervation of
nucleus accumbens is derived predominately from ventral tegmen-
tal area midbrain dopamine neurons; the medial and ventral parts
of the striatum receive projections from both ventral tegmental
area and substantia nigra pars compacta neurons, and the
Figure 8 Subtype analysis of dopamine neurons in Pitx3
WT/GFP
and Pitx3
GFP/GFP grafts. Immunohistochemistry for GFP (green),
GIRK2 (red) and Calbindin (blue) in coronal sections through the
striatum of representative animals from the Pitx3
WT/GFP (A) and
Pitx3
GFP/GFP (B) groups, 12 weeks after transplantation. The
boxed areas in the main panels are shown in greater detail as
individual colour channels on the left. The Pitx3
WT/GFP grafts
contained a mix of GFP
+ midbrain dopamine subtypes including
GIRK2
+/Calbindin
  (arrows), GIRK2
 /Calbindin
+ (ﬁlled arrow-
heads) and GIRK2
+/Calbindin
+ (empty arrowheads) neurons.
The Pitx3
GFP/GFP grafts were dominated by the GIRK2
 /
Calbindin
+ cell type (ﬁlled arrowheads) and contained few
GIRK2
+ cells (not shown). Quantiﬁcation of GIRK2
+ and
Calbindin
+ GFP expressing neurons in all grafted animals con-
ﬁrmed that there was a substantial difference in the midbrain
dopamine subtype composition between the two graft types,
with Pitx3
WT/GFP grafts (n=8; open bars) containing predomi-
nately the GIRK2
+/Calbindin
  subtype and Pitx3
GFP/GFP (n=7;
ﬁlled bars) grafts containing mainly GIRK2
 /Calbindin
+ cells.
Scale: 200mm.
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A9 neurons in the substantia nigra pars compacta (Bjo ¨rklund and
Lindvall, 1984). The selective loss of A9 neurons and correspond-
ing lack of innervation of the same dorsolateral region of
the striatum in both the Pitx3
GFP/GFP mouse brain and in
Pitx3
GFP/GFP transplanted rats suggests that the normal target spe-
ciﬁcity of A9 midbrain dopamine progenitors is an intrinsic prop-
erty, which is maintained after transplantation. This is in
agreement with earlier studies reporting that midbrain dopamine
neuronal subtypes contained in intrastriatal grafts display a
remarkable capacity to innervate their appropriate developmental
targets following intrastriatal grafting (Schultzberg et al., 1984;
Haque et al., 1997; Thompson et al., 2005). Although both
graft types contained large numbers of Calbindin
+ midbrain dopa-
mine neurons, most of which correspond to the A10 population,
TH
+ innervation of the ventromedial part of the striatum was not
signiﬁcantly improved above the lesion control level of around
50% in either group. This is likely to be due to the remaining
intrinsic, ventral tegmental area-derived innervation of this part
of the striatum in the partially lesioned animals. Previous studies
have shown that the level of spared host-derived innervation of
the striatum has an important impact on the ability of grafted
dopamine neurons to extend axons and innervate the host
(Doucet et al., 1989; Kirik et al., 2001; Thompson et al., 2005).
In the study by Kirik et al. (2001), it was found that ventral
mesencephalon grafts can signiﬁcantly improve striatal innervation
in animals where the intrinsic striatal dopamine innervation is
reduced to about 20% of normal, or less, but fail to provide sig-
niﬁcant innervation in animals with moderate lesions, where the
intrinsic level of innervation has not fallen below 50%. This
matches well with results from the present study, where a signif-
icant level of graft-derived innervation was only achieved in the
dorsolateral striatum, where the intrinsic innervation had been
reduced to 520%, but not in the ventromedial striatum, which
retained around half the normal level of innervation of the intact
system. Thus, while target speciﬁcity of grafted midbrain dopa-
mine neurons is largely an intrinsic property of the grafted cells,
signalling from the target itself plays an important permissive role
in mediating axonal growth.
In addition to investigating the signiﬁcance of A9/A10 graft
composition at the anatomical level, we also sought to assess
how this might affect functional activation of the host striatum.
To examine region-speciﬁc effects of the different graft-types
within the host striatum, immunohistochemistry for c-Fos, the pro-
tein product of the early immediate response gene c-Fos, was
performed on tissue from animals that received injection of
amphetamine 2h prior to perfusion. Expression of c-Fos has
previously been shown to be up-regulated following
amphetamine-induced release of dopamine from midbrain dopa-
mine terminals in the striatum and thus providing a useful readout
for functional activation of the post-synaptic target (Cenci et al.,
1992). Increased expression of c-Fos in the dorsolateral striatum
was seen only in animals that received Pitx3
WT/GFP ventral mesen-
cephalon grafts. This matches well the difference in the ability of
the two graft types to reinnervate the dorsolateral striatum and is
in line with the view that dopamine released from the
graft-derived axon terminals is the key mediator for functional
activation of the striatal target neurons. The lack of
amphetamine-induced c-Fos activation in the Pitx3
GFP/GFP grafted
animals suggests that volume transmission, i.e. diffusion of
released dopamine over distance from midbrain dopamine rich
grafts is, at best, an inefﬁcient means to normalize striatal
neuron activity in the Parkinson’s disease affected brain.
Taken together, these data point to an important relationship
between A9/A10 midbrain dopamine subtype composition and
functional impact that is mediated by the extent of graft-derived
innervation of the host striatum. This is in agreement with previ-
ous ﬁndings reporting a positive correlation between the number
of GIRK2
+ neurons in intrastriatal ventral mesencephalon grafts
and behavioural recovery (Kuan et al., 2007). It is worth noting,
however, that these results do not imply that the A10 neurons are
themselves unimportant for graft-mediated improvement in motor
function. Recent studies have shown signiﬁcantly better therapeu-
tic outcome following ventral mesencephalon grafting in patients
with preserved innervation of the ventral striatum (primarily inner-
vated by A10 midbrain dopamine neurons) relative to those with
more extensive denervation of the caudate putamen unit outside
of the grafted area (Piccini et al., 2005), and impaired functional
efﬁcacy following grafting in rodents when the intrinsic
A10-derived innervation of ventral striatal areas, including nucleus
accumbens, is subsequently removed (Breysse et al., 2007). So
while grafts with a predominately A10 composition by themselves
were ineffective in our study, we cannot rule out a supportive role
at the functional level for A10 neurons in mixed A9/A10 grafts.
This aspect needs to be addressed in future studies.
In conclusion, the present results demonstrate the importance of
midbrain dopamine neuronal subtype as a determinant of func-
tional impact following cell-based repair of the Parkinsonian brain.
A fundamental limitation imposed by the use of foetal donor tissue
is the inability to standardize the cell preparations prior to grafting.
In the case that procedural variations in the preparation and trans-
plantation of foetal ventral mesencephalon tissue (donor age, dis-
section technique, etc) will affect the relative numbers of A9 and
A10 subtypes in the resulting grafts, this may well represent an
important contributing factor in the variable therapeutic outcome
seen in ventral mesencephalon-grafted patients. The results also
have implications for the development of novel sources of trans-
plantable dopamine neurons. They highlight that beyond the abil-
ity to synthesize, store and release dopamine, transplanted cells
should possess the capacity to re-establish a terminal network
within speciﬁc regions of the caudate–putamen. Stem cells, par-
ticularly embryonic stem cells, are seen as a promising alternative
to foetal tissue with the important advantage that they are more
amenable to manipulation and standardization prior to grafting.
Encouragingly, recent studies have shown that procedures com-
monly used to produce midbrain dopamine neurons from embry-
onic stem cells result in the production of distinct TH
+ populations
with properties of either A9 or A10 midbrain dopamine subtypes
(Ferrari et al., 2006; Friling et al., 2009), and that grafting of these
cells can result in extensive innervation of the host striatum,
including the A9-speciﬁc dorsolateral region. None of these pro-
tocols, however, are known to direct the speciﬁcation of distinct
midbrain dopamine neuronal subtypes. In the protocols used cur-
rently, midbrain dopamine neuron subtypes are generated in an
Midbrain dopamine neuronal subtypes in cell therapy for Parkinson’s disease Brain 2010: 133; 482–495 | 493uncontrolled manner as a result of patterning procedures that are
more broadly geared towards generating ventralized midbrain
neuronal phenotypes from neuralized embryonic stem cells. In
the interest of generating highly standardized cell preparations
from embryonic stem cells, our results suggest that there is con-
siderable value in the further development of procedures that
allow for the directed differentiation and/or selection of speciﬁc
midbrain dopamine subtypes prior to grafting.
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